AMGN34:BVMF
Amgen Inc. BDR
R$Â 75.52
0.00%
(0.00) Siku 1
2 Okt, 16:56:00 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AMGN34...
Fungua
R$Â 75.76
Juu
R$Â 75.82
Chini
R$Â 75.32
Mtaji wa soko
217.90B
Wastani wa kiasi cha mauzo
376.00
Kiasi cha mauzo ya hisa
112.00
Juu kwa wiki 52
R$Â 83.06
Chini kwa wiki 52
R$Â 47.76
Hisa za wawekezaji
540.63M
Idadi ya wafanyakazi
elfu 32
Fungua
R$Â 75.76
Juu
R$Â 75.82
Chini
R$Â 75.32
Mtaji wa soko
217.90B
Wastani wa kiasi cha mauzo
376.00
Kiasi cha mauzo ya hisa
112.00
Juu kwa wiki 52
R$Â 83.06
Chini kwa wiki 52
R$Â 47.76
Hisa za wawekezaji
540.63M
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Motley Fool
·
saa 18 zilizopita
Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?
MarketWatch
·
siku 2 zilizopita
Amgen Inc. stock underperforms Friday when compared to competitors
Yahoo Finance
·
siku 3 zilizopita
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
Wasifu
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Kuhusu Amgen Inc. BDR
Afisa Mkuu Mtendaji (CEO)Robert A. Bradway
Wafanyakazielfu 31.5
Lilianzishwa1980
Makao makuuThousand Oaks, California, Marekani
Sekta-
Tovutiamgen.com